These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21114870)

  • 1. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
    Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A
    World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.
    Ulker V; Kuru O; Numanoglu C; Akbayır O; Polat I; Uhri M
    Arch Gynecol Obstet; 2014 May; 289(5):1087-92. PubMed ID: 24213097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
    Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node involvement in clinically apparent early ovarian cancer: a prospective study.
    Khouly NI; Elkelani OA; Elhalaby AF
    Eur J Gynaecol Oncol; 2017; 38(2):232-235. PubMed ID: 29953786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
    Minig L; Heitz F; Cibula D; Bakkum-Gamez JN; Germanova A; Dowdy SC; Kalogera E; Zapardiel I; Lindemann K; Harter P; Scambia G; Petrillo M; Zorrero C; Zanagnolo V; Rebollo JMC; du Bois A; Fotopoulou C
    Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
    Mueller JJ; Holzapfel M; Han CH; Santos K; Gunderson C; Moore K; Erickson B; Leath CA; Diaz E; Walsh C; Wethington SL; Dejbakhsh SZ; Barakat RR; Gardner GJ; Hyman DM; Soslow RA; Leitao MM
    Int J Gynecol Cancer; 2016 Jan; 26(1):120-4. PubMed ID: 26509849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
    Signorelli M; Guerra L; Pirovano C; Crivellaro C; Fruscio R; Buda A; Cuzzucrea M; Elisei F; Ceppi L; Messa C
    Gynecol Oncol; 2013 Nov; 131(2):395-9. PubMed ID: 23988414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
    Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
    Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.
    Brown JV; Mendivil AA; Abaid LN; Rettenmaier MA; Micha JP; Wabe MA; Goldstein BH
    Int J Gynecol Cancer; 2014 Oct; 24(8):1493-8. PubMed ID: 25078341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
    Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenectomy in surgical stage I epithelial ovarian cancer.
    Svolgaard O; Lidegaard O; Nielsen ML; Nedergaard L; Mosgaard BJ; Lidang M; Mogensen O; Kock K; Blaakaer J; Staehr E; Andersen ES; Grove A; Høgdall C
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):256-60. PubMed ID: 24447203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.
    Pereira A; Irishina N; Pérez-Medina T; Magrina JF; Magtibay PM; Kovaleva A; Rodríguez-Tapia A; Iglesias E
    Eur J Surg Oncol; 2013 Mar; 39(3):290-6. PubMed ID: 23290581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.